Critical Path Services relocates headquarters to Pennsylvania
The new facility is 5,760 square feet, and most of this space is said to be targeted for future company growth. In addition, Critical Path Services (CPS) will
Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus (ocrelizumab) to treat multiple sclerosis (MS).
Brendan’s StatLIA software allows researchers to quantitate proteins with measurable accuracy and improve assay performance through automated quality control. StatLIA also helps researchers troubleshoot sample preparation problems using